Corpus Intelligence IC Memo — SENTARA CAREPLEX HOSPITAL 2026-04-26 04:03 UTC
IC Memo — SENTARA CAREPLEX HOSPITAL
Investment Committee Memorandum | VA | 169 beds | Grade B | EBITDA uplift $22.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SENTARA CAREPLEX HOSPITAL

CCN 490093 | HAMPTON CITY, VA | 169 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SENTARA CAREPLEX HOSPITAL is a 169-bed suburban community hospital in HAMPTON CITY, VA with $302.5M in net patient revenue and a 9.3% operating margin. The hospital serves a payer mix of 30.5% Medicare, 3.5% Medicaid, and 66.0% commercial.

Thesis: Turnaround. Our ML models identify $22.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.3% to 16.6% (+736bps).

Net Revenue HCRIS$302.5M
Current EBITDA COMPUTED$28.0M
Operating Margin COMPUTED9.3%
Occupancy HCRIS58.2%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS27.6%
Distress Probability ML45.3%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
47
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 9.3% places it above the state median. Among 47 size-comparable peers (84-338 beds), the median margin is 5.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-338), prioritizing same-state peers. 47 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SENTARA CAREPLEX HOSPITAL (Target)VA169$302.5M9.3%
VIRGINIA HOSPITAL CENTER ARLINVA336$624.4M1.8%
CHILDRENS HOSPITAL OF THE KINGVA202$546.2M-9.9%
SENTARA LEIGH HOSPITALVA274$511.5M14.7%
INOVA LOUDOUN HOSPITAL CENTERVA189$510.3M22.9%
INOVA ALEXANDRIA HOSPITALVA303$456.5M26.3%
SENTARA VA. BEACH GENERAL HOSPVA239$443.9M15.2%
SENTARA RMH MEDICAL CENTERVA238$408.3M-22.8%
LEWIS GALE MEDICAL CENTERVA332$405.0M13.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $22.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.4M+210bp18mo
Cost to Collect4.5%2.5%$6.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.7M+122bp9mo
Clean Claim Rate88.0%96.0%$194K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.4M
Cost to Collect
$6.0M
Denial Rate Reduction
$6.0M
A/R Days Reduction
$3.7M
Clean Claim Rate
$194K
Total EBITDA Uplift$22.3M
Current EBITDA$28.0M
+ RCM Uplift+$22.3M
Pro Forma EBITDA$50.3M
Current Margin9.3%
Pro Forma Margin16.6%
WC Released (1x)$11.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$43.1M$407.6M9.45x56.7%
Base (11x exit)10.0x11.0x$43.1M$462.4M10.72x60.7%
Bull Case9.0x11.0x$38.8M$549.9M14.16x69.9%
Bull (12x exit)9.0x12.0x$38.8M$611.3M15.74x73.6%
Bear Case11.0x10.0x$47.5M$282.3M5.95x42.9%
Bear (11x exit)11.0x11.0x$47.5M$325.9M6.87x47.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 47 hospitals with 84-338 beds
  • Same-state prioritization (n=48)
  • Comp margins: P25=-4.1% / P50=5.2% / P75=15.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.